Price
Financials
Consolidated, Rs crore| Mar 2013 | Jun 2013 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 360 | 409 | 9 | 6 | 6 | 6 | 6 | 5 | 3 | 1 | 1 | 1 |
| Expenses | 352 | 398 | -9 | 73 | 8 | 8 | 7 | 5 | 4 | 49 | 1 | 373 |
| Operating Profit | 8 | 11 | 18 | -67 | -2 | -2 | -1 | -1 | -1 | -48 | 0 | -372 |
| OPM % | 2.2% | 2.6% | 204% | -1,116% | -25% | -43% | -16% | -14% | -52% | -3,731% | 4.8% | -31,800% |
| Other Income | 8 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 124 |
| Interest | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 9 | 8 | 16 | -69 | -3 | -4 | -3 | -2 | -3 | -50 | -1 | -250 |
| Tax % | 61% | 30% | -1% | 1% | 10% | -271% | 7% | 8% | -54% | -20% | 12% | -26% |
| Net Profit | 4 | 5 | 16 | -70 | -3 | 7 | -3 | -3 | -1 | -40 | -2 | -186 |
| EPS in Rs | 2.70 | 3.95 | 11.59 | -51.46 | -2.22 | 5.48 | -2.16 | -1.89 | -1.08 | -29.33 | -1.15 | -136.88 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 396 | 503 | 886 | 1,457 | 1,508 | 350 | 105 | 24 | 27 | 27 | 14 | 6 |
| Expenses | 364 | 468 | 852 | 1,417 | 1,475 | 375 | 138 | 53 | 36 | 80 | 65 | 427 |
| Operating Profit | 32 | 35 | 34 | 41 | 33 | -26 | -33 | -29 | -10 | -53 | -51 | -422 |
| OPM % | 8% | 7% | 3.8% | 2.8% | 2.2% | -7% | -32% | -121% | -36% | -199% | -354% | -7,096% |
| Other Income | 3 | 1 | 12 | 16 | 14 | 14 | 13 | -69 | 3 | 1 | 0 | 124 |
| Interest | 7 | 4 | 4 | 7 | 4 | 5 | 5 | 2 | 2 | 1 | 1 | 0 |
| Depreciation | 8 | 10 | 11 | 12 | 15 | 23 | 26 | 8 | 8 | 7 | 7 | 6 |
| Profit before tax | 20 | 22 | 31 | 38 | 28 | -39 | -52 | -108 | -16 | -61 | -58 | -304 |
| Tax % | 22% | 40% | 23% | 25% | 55% | -2% | 3% | -1% | 3% | -18% | -19% | |
| Net Profit | 16 | 13 | 24 | 27 | 12 | -38 | -53 | -107 | -17 | -50 | -47 | -228 |
| EPS in Rs | 12.91 | 10.68 | 18.54 | 20.05 | 10.44 | -26.36 | -35.67 | -79.15 | -12.47 | -36.61 | -34.46 | -168.44 |
| Dividend Payout % | 16% | 19% | 22% | 7% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -28% | -47% | -16% | -74% | ||
| Compounded Profit Growth | % | -12% | -9% | -21246% | ||
| Stock Price CAGR | -19% | -1% | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 103 | 81 | 78 | 151 | 122 | 73 | 21 | -97 | -113 | -163 | -210 | -397 |
| Borrowings | 157 | 216 | 342 | 322 | 789 | 721 | 738 | 740 | 752 | 763 | 768 | 764 |
| Other Liabilities | 55 | 85 | 80 | 79 | 233 | 222 | 226 | 178 | 170 | 161 | 161 | 42 |
| Total Liabilities | 327 | 394 | 512 | 566 | 1,159 | 1,030 | 999 | 835 | 822 | 774 | 733 | 422 |
| Fixed Assets | 173 | 193 | 200 | 235 | 276 | 433 | 405 | 162 | 154 | 147 | 140 | 137 |
| CWIP | 45 | 74 | 135 | 201 | 202 | 27 | 19 | 0 | 0 | 0 | 0 | 0 |
| Investments | 24 | 23 | 2 | 2 | 2 | 2 | 2 | 171 | 169 | 169 | 169 | 169 |
| Other Assets | 85 | 104 | 176 | 128 | 679 | 568 | 574 | 503 | 500 | 459 | 424 | 116 |
| Total Assets | 327 | 394 | 512 | 566 | 1,159 | 1,030 | 999 | 835 | 822 | 774 | 733 | 422 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 14 | 23 | 15 | 0 | 4 | -232 | -98 | -25 | -14 | -14 | -7 | -4 |
| Cash from Investing Activity | -23 | -24 | -65 | 0 | -98 | -45 | -9 | -2 | 5 | 4 | -3 | -0 |
| Cash from Financing Activity | 5 | -1 | 51 | 0 | 53 | 427 | -69 | 19 | 11 | 10 | 9 | 5 |
| Net Cash Flow | -4 | -2 | 1 | 0 | -40 | 150 | -175 | -8 | 1 | -0 | -1 | 0 |
| Free Cash Flow | -11 | -1 | -49 | 0 | -110 | -289 | -106 | -18 | -9 | -13 | -7 | -4 |
| CFO/OP | 45% | 71% | 58% | 0% | 26% | -667% | 380% | 75% | 49% | 148% | 13% | 8% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16 | 16 | 15 | 11 | 4 | 99 | 495 | 1,732 | 7,098 | 6,471 | 5,807 | 9,597 |
| Inventory Days | 26 | 32 | 31 | 17 | 11 | 12 | 56 | 230 | 114 | 36 | 19 | 20 |
| Days Payable | 17 | 21 | 10 | 4 | 2 | 38 | 176 | 828 | 2,641 | 2,554 | 2,430 | 4,894 |
| Cash Conversion Cycle | 25 | 27 | 36 | 25 | 12 | 73 | 375 | 1,134 | 4,572 | 3,952 | 3,397 | 4,723 |
| Working Capital Days | 14 | 16 | -16 | -4 | 5 | 67 | 358 | 1,224 | 4,735 | 4,355 | 3,702 | 5,772 |
| ROCE % | 11% | 10% | 9% | 9% | 10% | 5% | -3% | -5% | -5% | -2% | -9% | -10% |
| Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% | 34.94% |
| FIIs | 9.75% | 9.75% | 9.75% | 9.11% | 3.50% | 3.50% | 3.50% | 3.50% | 3.50% | 0.00% | 0.00% | 0.00% |
| DIIs | 3.00% | 2.48% | 2.48% | 2.48% | 2.49% | 2.49% | 2.49% | 2.49% | 2.49% | 2.48% | 2.48% | 1.51% |
| Government | 0.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 51.46% | 52.82% | 52.82% | 53.46% | 59.07% | 59.07% | 59.07% | 59.07% | 59.07% | 62.57% | 62.57% | 63.54% |
| No. of Shareholders | 8,694 | 8,591 | 8,515 | 8,509 | 8,722 | 8,708 | 8,555 | 8,571 | 8,640 | 8,640 | 9,312 | 10,223 |
Fundamentals
Market Cap₹ 4.08 Cr.
Current Price₹ 3.01
Book Value₹ -283
ROCE-9.70 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-74%
Compounded Profit Growth (TTM)-21246%
Consolidated figures.
Valuation
Market capRs 4 Cr
Enterprise valueRs 769 Cr
Price to book-0.02x
Price to sales0.72x
EV / sales129.54x
Earnings yield-5347.27%
P/B, 3-year average-0.05x
P/B, 5-year average0.05x
Profitability
Operating margin (excl. other income)-354.48%
Operating margin (incl. other income)-352.46%
EBITDA margin-5007.24%
Pre-tax margin-5122.05%
Net profit margin-3845.12%
Net margin, latest quarter-15863.25%
ROE27.01%
ROCE-9.70%
ROA-6.20%
ROE, 3-year average28.41%
ROCE, 3-year average-7.11%
ROA, 3-year average-4.82%
ROE, 5-year average89.18%
ROCE, 5-year average-8.42%
ROA, 5-year average-6.19%
ROIC (approx.)-43.05%
Tax rate19.40%
Other income / net worth-0.15%
Growth
Sales growth (latest year)-46.11%
Sales CAGR, 3 years-15.84%
Sales CAGR, 5 years-47.16%
Sales growth QoQ39.29%
Sales growth YoY (latest quarter)-74.73%
Per share
EPS (TTM)Rs -168.44
EPS (latest year)Rs -34.46
EPS (latest quarter)Rs -136.88
EPS, 3-year averageRs -27.85
EPS, 5-year averageRs -39.67
Book value per shareRs -144.81
Sales per shareRs 4.38
Cash flow per shareRs -2.94
Free cash flow per shareRs -2.95
Efficiency
Asset turnover0.02x
Fixed asset turnover0.10x
Inventory turnover19.67x
Inventory days19 days
Debtor days9597 days
Debtors turnover0.04x
Creditor days4894 days
Cash conversion cycle4723 days
Working capital days5772 days
Leverage
Total debtRs 768 Cr
Cash and bankRs 2 Cr
Net debtRs 765 Cr
Debt to equity-3.91x
Interest coverage-723.40x
Owners' fund to total sources-26.80%
Debt to assets104.78%
Cash flow
Cash from Operating Activity (latest year)Rs -4 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 5 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -4 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Statement figures
Net sales (TTM)Rs 6 Cr
Net sales (latest year)Rs 14 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -51 Cr
Operating profit (latest quarter)Rs -372 Cr
Other income (TTM)Rs 124 Cr
EBITDA (TTM)Rs -297 Cr
PBDT (TTM)Rs -298 Cr
Profit before tax (TTM)Rs -304 Cr
Tax (latest year)Rs -11 Cr
Net profit (TTM)Rs -228 Cr
Net profit (latest year)Rs -47 Cr
Net profit (latest quarter)Rs -186 Cr
Depreciation (TTM)Rs 6 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 11 Cr
Total expenditure (latest year)Rs 65 Cr
Total income (latest year)Rs 15 Cr
Share capitalRs 14 Cr
ReservesRs -210 Cr
Shareholders' fundsRs -196 Cr
Total assetsRs 733 Cr
Net blockRs 140 Cr
InvestmentsRs 169 Cr
ReceivablesRs 379 Cr
InventoryRs 1 Cr
Other liabilitiesRs 161 Cr
Shares outstanding (crore)1.36
Ownership
Promoter holding34.94% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | ALCHEM | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -13.7% | -2.8% | -10.9 pts |
| 1 month | -10.0% | -6.8% | -3.2 pts |
| 3 months | -65.2% | -7.6% | -57.6 pts |
| 6 months | -40.0% | +0.4% | -40.4 pts |
| 1 year | +215.0% | -9.9% | +224.9 pts |
| 2 years | +70.3% | -13.6% | +83.8 pts |
| 3 years | -41.1% | +14.2% | -55.3 pts |
| 5 years | -86.8% | +27.9% | -114.7 pts |
Red flags
F-score 3 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | Receivables outrunning sales Receivables grew -11% vs sales -46% in 2020 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2020Sales ₹1 Cr -80.0% vs Sep 2019.
Net loss ₹186 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2020-09-22 | Annual General Meeting | |
| 2019-09-20 | Annual General Meeting | |
| 2018-09-17 | Annual General Meeting (Date Revised) | |
| 2017-09-07 | Annual General Meeting | |
| 2016-09-08 | Annual General Meeting | |
| 2015-09-23 | Annual General Meeting | |
| 2014-09-23 | Annual General Meeting And Dividend Re.1/- Per Share | |
| 2013-09-24 | Annual General Meeting/Dividend Rs 1.5/- Per Share | |
| 2012-09-25 | Annual General Meeting/Dividend Rs 2 Per Share | |
| 2011-09-22 | Annual General Meeting And Dividend Rs.2/- Per Share | |
| 2010-09-20 | Annual General Meeting And Dividend Rs.2/- Per Share | |
| 2009-09-23 | Agm/Div-Rs.2/- Per Share | |
| 2008-09-24 | Agm/Dividend - 25% | |
| 2007-12-19 | Agm/Dividend - 25% |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Alchemist Ltd?
Alchemist Ltd (ALCHEM) has a market capitalisation of Rs 4.08 Cr. at the 2021-08-30 close.
What were Alchemist Ltd's latest quarterly results?
In the Sep 2020 quarter, Alchemist Ltd sales was Rs 1 Cr (-80.0% vs Sep 2019) with a net loss of Rs 186 Cr.